申请人:KHOSLA CHAITAN
公开号:US20090312260A1
公开(公告)日:2009-12-17
Administering an effective dose of a tTGase inhibitor to a Celiac or dermatitis herpetiformis patient reduces the toxic effects of toxic gluten oligopeptides, thereby attenuating or eliminating the damaging effects of gluten.
给予具有有效剂量的tTGase抑制剂给予具有乳糜泻或疱疹性荨麻疹的患者,可以减少有毒的麸质寡肽的毒性影响,从而减轻或消除麸质的有害影响。